| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 02/09/2005 | EP1504762A1 Medicine for prevention of and treatment for amyloidosis |
| 02/09/2005 | EP1504761A1 Difructose anhydride-containing composition and use thereof |
| 02/09/2005 | EP1503769A1 Antibiotic/benzoyl peroxide dispenser |
| 02/09/2005 | EP1503729A1 Composition and the use thereof as a pharmaceutical or cosmetic formulation for external use |
| 02/09/2005 | EP1307209B1 Cardioplegic solution |
| 02/09/2005 | EP1111995B1 Topical dermal antimicrobial compositions |
| 02/09/2005 | CN1578676A Lox concentration of peroxide for treating or preventing vaginal infections |
| 02/09/2005 | CN1578653A Cosmetics and treatment method for promoting maturation of cornified envelopes |
| 02/09/2005 | CN1188157C Chinese herbal medicine tumor-eliminating drop |
| 02/09/2005 | CN1188154C Quick-acting antalgesic-antipruritic tincture and preparing method thereof |
| 02/09/2005 | CN1188148C Process for preparing staltic-antagic medicine to treat trauma |
| 02/09/2005 | CN1188137C Use of erythrogenin and molecule with active EPO receptor ability or analog EPO activation in pharmacy |
| 02/09/2005 | CN1188136C Buffered composition for dialysis |
| 02/08/2005 | US6852870 Omega-3 fatty acids in the treatment of depression |
| 02/08/2005 | US6852760 Compositions and methods for treatment for glucose metabolism disorders |
| 02/03/2005 | WO2005010481A2 Preparation and use of gold glyconanoparticles |
| 02/03/2005 | WO2005009352A2 Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
| 02/03/2005 | WO2005009338A2 Method of inhibiting atf/creb and cancer cell growth and pharmaceutical compositions for same |
| 02/03/2005 | WO2004105912A3 Method of producing eggshell powder |
| 02/03/2005 | WO2004078122A3 Invisible patch for active agnet controlled delivery |
| 02/03/2005 | WO2004071425A3 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions |
| 02/03/2005 | US20050026996 A taxane such as paclitaxel or docetaxel joined by a hydrolyzable bond to one or more oligomers having a polyethylene glycol moiety; amphiphilic drug conjugate with improved water solubility without drastic increase in molecular weight |
| 02/03/2005 | US20050026870 Use of bisphosphonates for the treatment of osteogenesis imperfecta |
| 02/03/2005 | US20050026283 Using electric field modification to transfer components across cell barriers; organelle transfer; in vitro fertility |
| 02/03/2005 | US20050025840 Compositions and methods directed towards sore muscles and joints |
| 02/03/2005 | US20050025839 Formulation approach to enhance transporter-mediated drug uptake |
| 02/03/2005 | US20050025811 Calcium carbonate granulation |
| 02/03/2005 | US20050025807 Cured porous calcium phosphate material and uses thereof |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | US20050025705 Causing occlusion to blood vessels using ferric chloride solution, introducing test compound and measuring physical or chemical alterations; simple, sensitive screening technique |
| 02/03/2005 | DE10331439B3 Magnetische Nanopartikel mit verbesserten Magneteigenschaften Magnetic nanoparticles with improved magnetic properties |
| 02/03/2005 | DE10329908A1 Composition comprising xenon and local anesthetic, useful in regional or local anesthetic procedures |
| 02/03/2005 | CA2532730A1 Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
| 02/03/2005 | CA2525829A1 Method of inhibiting atf/creb and cancer cell growth and pharmaceutical compositions for same |
| 02/02/2005 | EP1502604A1 Use of nitric oxide mimetics in cancer treatment |
| 02/02/2005 | EP1502586A1 Preparations for the application of anti-inflammatory agents |
| 02/02/2005 | EP1501563A1 Carbon nanotubules for storage of nitric oxide |
| 02/02/2005 | EP1501545A2 Use of tnfalpha antibodies and another drug |
| 02/02/2005 | EP1501523A1 Carbon monoxide as a biomarker and therapeutic agent |
| 02/02/2005 | EP1501497A2 Catechin multimers as therapeutic drug delivery agents |
| 02/02/2005 | EP1501359A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 02/02/2005 | EP1404334A4 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 02/02/2005 | EP1318820B1 Medicament containing sub-anesthetic concentrations of xenon for use in the treatment of cardiovascular diseases |
| 02/02/2005 | CN1575183A Superfine aqueous dispersion of noble metal for head massage |
| 02/02/2005 | CN1572320A Method for erythropoietin administration using pharmacokinetic and pharmacodynamic modeling |
| 02/02/2005 | CN1572304A Medicinal composition for treating diabetes mellitus containing ring Pro |
| 02/02/2005 | CN1187091C Oral vanadium replenishing agent with bimetallic oxide as carrier and its preparation and operation guide |
| 02/02/2005 | CN1187071C Liver cancer treating medicine and its preparation method |
| 02/02/2005 | CN1187070C Suppository for treating piles and other anorectal diseases and its preparation method |
| 02/02/2005 | CN1187065C Ointment for treating dermatopathy and preparing process thereof |
| 02/02/2005 | CN1187064C Medicine for treating epidemic hemorrhagic fever |
| 02/02/2005 | CN1187060C Extracts of shark cartilage, its preparation method and usage |
| 02/02/2005 | CN1187057C Trivalent cerium carried rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof |
| 02/02/2005 | CN1186983C Technique for detoxicating white spot syndrome virus of prawn |
| 02/01/2005 | US6849277 Composition for moist skin |
| 02/01/2005 | US6849268 Administering especially to an infant or toddler a source of calcium and a fat blend that is low in palmitic acid. |
| 02/01/2005 | CA2296080C Ophthalmic compositions containing galactomannan polymers and borate |
| 01/27/2005 | WO2005007328A1 Metal colloid solution |
| 01/27/2005 | WO2005007178A1 Treatment of malodour |
| 01/27/2005 | WO2005007174A2 Synergistic antimicrobial ophthalmic combination |
| 01/27/2005 | WO2005007173A1 Use of nitrite salts for the treatment of cardiovascular conditions |
| 01/27/2005 | WO2005007170A1 Method for treating irritable bowel syndrome using laxatives |
| 01/27/2005 | WO2005007117A2 Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
| 01/27/2005 | WO2005007115A2 Pharmaceutical composition for inhibiting acid secretion |
| 01/27/2005 | WO2005007077A2 Antimicrobial silver ion complex resinates |
| 01/27/2005 | WO2005007071A2 Skin formulation |
| 01/27/2005 | WO2004073623A9 Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions |
| 01/27/2005 | WO2004073584A3 Cystitis treatment with high dose chondroitin sulfate |
| 01/27/2005 | US20050020556 Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes |
| 01/27/2005 | US20050020523 Modified antisense nucleotides complementary to a section of the human haras gene |
| 01/27/2005 | US20050020498 Apo-2 ligand/trail formulations |
| 01/27/2005 | US20050019921 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 01/27/2005 | US20050019783 Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expression |
| 01/27/2005 | US20050019431 Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
| 01/27/2005 | US20050019429 Administering therapeutically-effective amount of Quercetin or Quercetin Glycosides(extracted from plant source selected from onions and apples) and Epican Forte(mixture of proline, lysine, arginine, vitamin c, n-acetylcystein, selenium, copper, magnesium, manganese) |
| 01/27/2005 | US20050019425 Animal feeds contains selenium, for promoting hair growth |
| 01/27/2005 | US20050019423 Method for treating amyotrophic lateral sclerosis |
| 01/27/2005 | US20050019422 Two therapeutical active agents are not contacting from one another, each by entrapping in a multiplicity of particles or beads; a carboxylic acid, or a salt or ester thereof; peroxides; stability |
| 01/27/2005 | US20050019414 Low temperature interconnection of nanoparticles |
| 01/27/2005 | US20050019343 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 01/27/2005 | US20050019330 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta |
| 01/27/2005 | US20050019319 aspirin, magnesium, and nattokinase, and either niacin or nitroglycerine, especially in the form of a chewable tablet, nasal spray, or suppository |
| 01/27/2005 | US20050019289 Hair repairing liquid comprising water dispersed with ultrafine particle titanium group metal by plasma underwater discharge and method and system for producing the same |
| 01/27/2005 | US20050019258 Therapy for incontinence; insertion of cooling fluid into bladder of guinea pig in prevence of test drug; measuring reduction of transition point of bladder contraction ; drug screening |
| 01/27/2005 | CA2537222A1 Use of nitrite salts for the treatment of cardiovascular conditions |
| 01/27/2005 | CA2531564A1 Pharmaceutical composition for inhibiting acid secretion |
| 01/26/2005 | EP1500398A1 Herbo-mineral formulation for refractory leukemias and lymphomas |
| 01/26/2005 | EP1500397A1 Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases |
| 01/26/2005 | EP1499730A1 Immunoconjugates for the treatment of tumours |
| 01/26/2005 | EP1499333A2 Methods of treating ileus |
| 01/26/2005 | EP1499331A2 Salt solution for colon cleansing |
| 01/26/2005 | EP1499330A1 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans |
| 01/26/2005 | EP1499329A1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 01/26/2005 | EP1499328A1 Methods of treating necrotizing enterocolitis |
| 01/26/2005 | EP1499325A1 Methods and compositions for inhibition of irritation by disaccharide and metal ions |
| 01/26/2005 | EP1499324A1 Method for treating and preventing hyperparathyroidism |
| 01/26/2005 | EP1499315A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia |
| 01/26/2005 | EP1499294A2 Transport system in biological systems |
| 01/26/2005 | EP1499189A1 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium |
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |